Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK
- Canagliflozin: A Novel SGLT2 Inhibitor for Type 2 Diabetes Mellitus. Kaushal, Shaveta; Singh, Harmanjit; Thangaraju, Pugazhenthan; Singh, Jasbir // North American Journal of Medical Sciences;Mar2014, Vol. 6 Issue 3, p107
Diabetes Mellitus continues to be a major non- communicable disease with global burden of 366 million at present and projected to increase to 439 to 552 million by 2030, India being the hub of diabetes. Sodium glucose transporter 2 (SGLT2) inhibitors presents a new class of anti-diabetic drugs...
- INCRETIN DRUGS FOR TYPE 2 DIABETES. Kenny, Colin // Pulse;12/17/2008, Vol. 68 Issue 44, p30
The article presents pointers in treating type 2 diabetes. The incretin effect refers to the hormones produced by the gastrointestinal (GI) tract in response to eating. It notes that exenatide slows gastric emptying and promotes satiety centrally. These mechanisms are connected with diminished...
- Physical activity and type 2 diabetes mellitus. // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS18
The article presents findings of studies conducted on examining the affect of physical activity in the treatment and prevention of type 2 diabetes mellitus. It mentions that regular physical activity significantly improves glycaemic control and reduces cardiovascular risk factors in patients...
- Intensified treatment with insulin detemir improved glycemic control, weight loss. // Endocrine Today;Oct2011, Vol. 9 Issue 10, p20
The article reports that a randomized trial has found that adding insulin detemir to a treatment regimen of metformin and liraglutide resulted to improved glycemic control and sustained weight loss for up to 52 weeks in patients with type 2 diabetes.
- Can 15 LB reverse diabetes? Davis, James; R.M.D. // Cortlandt Forum;11/25/95, Vol. 8 Issue 11, p87
Answers the question on studies proving that small weight loss can reverse adult-onset diabetes mellitus. Indication of the little effect of a small amount of weight loss.
- Insulin-based therapies in type 2 diabetes. // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS32
The article presents several studies conducted on examining the insulin-based therapies in type 2 diabetes. One study reveals that patients with type 2 diabetes assigned to receive a basal, biphasic or prandial insulin regimen, the mean glycated haemoglobin levels at one year were similar in the...
- The 2012 SEMDSA Treatment Algorithm for Type 2 Diabetes. // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS36
Several tables are presented discussing 2012 Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) Treatment Algorithm for type 2 diabetes including one on antihyperglycaemic agents used in type 2 diabetes and antihyperglycaemic agents used in type 2 diabetes.
- Should GPs lower HbA1c targets? Moberly, Tom // GP: General Practitioner;5/7/2010, p26
The article focuses on the debate that whether hemoglobin A1c (HbA1c) targets should be lowered or not in patients with type-2 diabetes. It states that action to control cardiovascular risk in diabetes (ACCORD) study published in the 2010 issue of the periodical "Diabetes Care" reveals that...
- The antidiabetic gutsy role of metformin uncovered? Burcelin, Rémy // Gut;May2014, Vol. 63 Issue 5, p706
The author comments on the research study concerning on the medical role of metformin as treatment for lowering hyperglycaemia in type 2 diabetic patients. He mentions the antidiabetic effect of metformin abrogated by an antibiotic treatment reinforcing the significant of gut microbiota. He also...